Anna López‐Ferrer
Impact in
- Dermatology top 2%
- Dermatology and Skin Diseases
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- Galectins and Cancer Biology
Papers in ⓘ
- Immunology 44
- Psoriasis: Treatment and Pathogenesis 38
- Galectins and Cancer Biology 5
- Rheumatology 21
- Spondyloarthritis Studies and Treatments 20
- Rheumatoid Arthritis Research and Therapies 8
- Co-authors
- L. Puig (29 shared papers)Eva Vilarrasa (14 shared papers)Carme de Bolós (9 shared papers)Carlos Barranco (5 shared papers)Marta Garrido (3 shared papers)Ignasi Gich (2 shared papers)A. Alomar (2 shared papers)A. Laíz (5 shared papers)
In The Last Decade
Anna López‐Ferrer
54 papers receiving 922 citations
Peers
Comparison fields: 5 of 63
- Dermatology 303
- Immunology 630
- Rheumatology 179
- Hematology 75
- Pathology and Forensic Medicine 97
Countries citing papers authored by Anna López‐Ferrer
This map shows the geographic impact of Anna López‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna López‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna López‐Ferrer more than expected).
Fields of papers citing papers by Anna López‐Ferrer
This network shows the impact of papers produced by Anna López‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna López‐Ferrer. The network helps show where Anna López‐Ferrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna López‐Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 75 | |
| 2 | 2000 | 72 | |
| 3 | 2018 | 57 | |
| 4 | 2016 | 53 | |
| 5 | 2018 | 51 | |
| 6 | 2012 | 46 | |
| 7 | 2017 | 43 | |
| 8 | 2013 | 43 | |
| 9 | 2001 | 29 | |
| 10 | 2005 | 29 | |
| 11 | 2002 | 29 | |
| 12 | 2007 | 28 | |
| 13 | 2013 | 27 | |
| 14 | 2019 | 26 | |
| 15 | 2017 | 22 | |
| 16 | 2012 | 21 | |
| 17 | 1999 | 19 | |
| 18 | 2018 | 19 | |
| 19 | 2021 | 18 | |
| 20 | 2015 | 18 |
About Anna López‐Ferrer
Anna López‐Ferrer is a scholar working on Immunology, Rheumatology, Dermatology, Molecular Biology and Hematology, having authored 55 papers that have together received 935 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (38 papers), Spondyloarthritis Studies and Treatments (20 papers), Dermatology and Skin Diseases (12 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Glycosylation and Glycoproteins Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Galectins and Cancer Biology (5 papers). The work is most often cited by research in Dermatology (303 citations), Immunology (630 citations), Rheumatology (179 citations), Hematology (75 citations) and Pathology and Forensic Medicine (97 citations). Anna López‐Ferrer has collaborated with scholars based in Spain, Russia and Germany. Frequent co-authors include L. Puig, Eva Vilarrasa, Carme de Bolós, Carlos Barranco, Marta Garrido, Ignasi Gich, A. Alomar, A. Laíz, D. Vidal and J.M. Carrascosa. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, Journal of Dermatological Treatment, Actas Dermo-Sifiliográficas, British Journal of Dermatology and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.